Lipidomics research provides clues for drug resistance in schizophrenia

(Skolkovo Institute of Science and Technology (Skoltech)) Researchers from Skoltech and the Mental Health Research Center have found 22 lipids in the blood plasma of people with schizophrenia that were associated with lower symptom improvement over time during treatment. The results show that different levels of symptom improvement are associated with different alterations in lipid levels. These can help track resistance to medication that affects over a third of patients and help further the understanding of the underlying mechanisms of disease manifestation and treatment response
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news